These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7542753)

  • 1. Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study.
    Akpolat T; Arik N; Günaydin M; Utaş C; Dilek K; Caglar S; Candan F; Süleymanlar G; Paydaş S; Sen S
    Nephrol Dial Transplant; 1995; 10(4):479-80. PubMed ID: 7542753
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
    Elzouki AN; Bushala M; Tobji RS; Khfaifi M
    Nephrol Dial Transplant; 1995; 10(4):475-6. PubMed ID: 7542751
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies.
    Huraib S; al-Rashed R; Aldrees A; Aljefry M; Arif M; al-Faleh FA
    Nephrol Dial Transplant; 1995; 10(4):470-4. PubMed ID: 7623989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus antibodies among risk groups in Turkey.
    Köksal I; Biberoğlu K; Biberoğlu S; Koç F; Ayma Y; Aker F; Köksal H
    Infection; 1991; 19(4):228-9. PubMed ID: 1917033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus antibodies in patients on hemodialysis.
    San Miguel G; Crespo J; Echevarria S; D'Francisco A; Gomez Ullate P; Pons Romero F
    Infect Control Hosp Epidemiol; 1992 May; 13(5):254, 256. PubMed ID: 1375612
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria.
    Ummate I; Denue BA; Kida IM; Ohioma OJ; Baba DB; Goni W
    Pan Afr Med J; 2014; 19():305. PubMed ID: 25883732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests.
    Beccari M; Sorgato G; Rizzolo L; Veneroni G
    Nephron; 1993; 63(2):238. PubMed ID: 7680775
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
    Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
    Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
    Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
    Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients.
    Alavian SM; Einollahi B; Hajarizadeh B; Bakhtiari S; Nafar M; Ahrabi S
    Nephrology (Carlton); 2003 Oct; 8(5):256-60. PubMed ID: 15012714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-HCV positivity in hemodialysis and renal transplant patients at our center.
    Bilgin N; Simşek H; Haberal M
    Transplant Proc; 1993 Dec; 25(6):3261-2. PubMed ID: 7505501
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers.
    Elisaf M; Tsianos E; Mavridis A; Dardamanis M; Pappas M; Siamopoulos KC
    Nephrol Dial Transplant; 1991; 6(7):476-9. PubMed ID: 1717891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays.
    Fabrizi F; Raffaele L; Bacchini G; Guarnori I; Pontoriero G; Erba G; Locatelli F
    Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of hepatitis C virus genotypes in haemodialysis patients of Guilan, northern Islamic Republic of Iran.
    Joukar F; Khalesi AK; Jafarshad R; Rahimabadi MS; Mansour-Ghanaei F
    East Mediterr Health J; 2012 Mar; 18(3):236-40. PubMed ID: 22574476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.